Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2015 Q1- Text added to 2015 Q2
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
New words:
agonist, Alberio, antiviral, automatically, aware, bind, Biotech, breakthrough, Carlo, cholestatic, cholesterol, comparison, contraindication, Cymabay, discern, dissolution, Durect, EU, exhibit, farnesoid, forseeable, fourth, FXR, Galectin, gallstone, Galmed, Genfit, GSK, Index, Intercept, Islet, July, ledipasvir, lipid, Medicnova, metabolic, minimum, Monte, NGM, originally, placebo, prone, PSU, ranking, Raptor, rare, receptor, shareholder, Shire, simulation, space, syndrome, Tobira, TSR, Viking
Valuein 2015 Q1 filing- Value in 2015 Q2 filing
Original filings
Filing view